Top

Published in:

Open Access 01-12-2020 | Disseminated Intravascular Coagulation | Editorial

Thrombosis management in times of COVID-19 epidemy; a Dutch perspective

Author: Hugo ten Cate

Published in: Thrombosis Journal | Issue 1/2020

Excerpt

The current pandemic of COVID-19 infection [1] has caused major shifts in healthcare organization, towards far more and acute attention for patients suspected from COVID-19 infection at the potential cost of less attention for “regular” care. Obviously, the occurrence of this pandemic does not diminish the burden of other diseases, rather the focus is temporarily shifted towards infectious diseases; while this shift in focus is fully appreciable and also necessary to deal with the huge impact of COVID-19 infections throughout the world, it is important not to forget some essential matters that are part of our regular work. …

www.Who.int. WHO director speech March 11, 2020.

Driggin E, Madhavan MV, Bikdeli B, et al Cardiovascular considerations for patients, health care worklers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am College Cardiol 2020; journal pre-proof: https://doi.org/https://doi.org/10.1016/j.jacc.2020.03.031.

Lippi G, Favaloro E. D-dimer is associated with severity of coronavirus disease 2019 (COVID-19): a meta-analysis. Thromb Haemost. 2020; https://doi.org/10.1055/s-0040-1709650. [Epub ahead of print] No abstract available.

Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020;00:1–2. https://doi.org/10.1111/jth.14781.CrossRef

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14768 [Epub ahead of print] PubMed PMID:32073213.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14817.

www.NHG.org. Overzetten VKA naar DOAC tijdens corona epidemie. Geersing GJ, Huisman MV, ten Cate H, Kruip M. In Dutch.

Title: Thrombosis management in times of COVID-19 epidemy; a Dutch perspective
Author: Hugo ten Cate
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Disseminated Intravascular Coagulation
Direct Oral Anticoagulant
COVID-19
Thrombosis
Direct Oral Anticoagulant
Low Molecular Weight Heparin
Published in: Thrombosis Journal / Issue 1/2020
Electronic ISSN: 1477-9560
DOI: https://doi.org/10.1186/s12959-020-00220-3

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Thrombosis management in times of COVID-19 epidemy; a Dutch perspective

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

The association of alcohol with circulating total fibrinogen and plasma clot density is mediated by fibrinogen and FXIII genotypes

The effect of civil and military flights on coagulation, fibrinolysis and blood flow: insight from a rat model

Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure

Factor V Leiden 1691G > A mutation and the risk of recurrent pregnancy loss (RPL): systematic review and meta-analysis

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page